Bank Vontobel AG Share Price

Certificat

RMBE4V

CH1300251084

Market Closed - Bid/Ask 16:20:00 17/06/2024 BST After market 16:15:00
102.5 CHF -0.10% Intraday chart for Bank Vontobel AG 102.3 -0.20%
1 month-1.06%
3 months+1.18%
Date Price Change

Delayed Quote Swiss Exchange

Last update June 17, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
RMBE4V
ISINCH1300251084
Date issued 24/11/2023
Strike 86.79 CHF
Maturity 26/05/2025 (341 Days)
Parity 0.09 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 103.7 CHF
Lowest since issue 100.1 CHF
Spread 8 CHF
Spread %0.78%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.2 USD
Average target price
110.3 USD
Spread / Average Target
+3.85%
Consensus
  1. Stock Market
  2. Certificates
  3. RMBE4V Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW